Fisher Clinical Services has the industry’s largest network of fully owned cGMP facilities strategically located around the world to support the conduct of clinical trials.
Our 20 purpose-built GMP/GDP compliant facilities—located across five continents—provide the global presence, information systems and high quality standards to provide clients the flexibility, access and assurance needed for their clinical trial. Our continued investment in cold chain storage capacity, as well as distribution capability across the network, mirrors the industry’s evolution to handle increased quantities of complex cold chain biologics across many continents. Supplementing these 20 facilities are over 30 partner depots across the world, specifically chosen to facilitate drug type or local regulatory requirements.
Each facility is staffed with a team of highly trained professionals who bring a depth of expertise in managing clinical trials, from protocol design through to investigator site receipt of clinical materials. This global expertise combined with an understanding of local requirements and regulations, language proficiency and established working relationships with key parties across the supply chain, allow us to support the movement, management and delivery of supplies to over 150 countries across all therapeutic indications.
Our teams will work with you to develop a clinical supply chain solution specific to the unique needs of your program or trial. With exposure to multinational trials and thousands of protocols each year, Fisher Clinical Services has developed the industry’s best practices in clinical supply chain management.
We offer packaging, labeling, relabeling (blinded and open label), storage and distribution of ambient and cold chain clinical trial materials, import/export services (including Importer of Record capability in more than 25 countries to date), comparator and ancillary sourcing, returns and destruction of supplies across our network.